» Articles » PMID: 34899188

Microglia in Alzheimer's Disease: A Target for Therapeutic Intervention

Overview
Specialty Cell Biology
Date 2021 Dec 13
PMID 34899188
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is one of the most common types of age-related dementia worldwide. In addition to extracellular amyloid plaques and intracellular neurofibrillary tangles, dysregulated microglia also play deleterious roles in the AD pathogenesis. Numerous studies have demonstrated that unbridled microglial activity induces a chronic neuroinflammatory environment, promotes β-amyloid accumulation and tau pathology, and impairs microglia-associated mitophagy. Thus, targeting microglia may pave the way for new therapeutic interventions. This review provides a thorough overview of the pathophysiological role of the microglia in AD and illustrates the potential avenues for microglia-targeted therapies, including microglial modification, immunoreceptors, and anti-inflammatory drugs.

Citing Articles

Pathogenesis and therapeutic applications of microglia receptors in Alzheimer's disease.

Fu J, Wang R, He J, Liu X, Wang X, Yao J Front Immunol. 2025; 16:1508023.

PMID: 40028337 PMC: 11867950. DOI: 10.3389/fimmu.2025.1508023.


Neurodegenerative diseases and neuroinflammation-induced apoptosis.

Huang S, Lu Y, Fang W, Huang Y, Li Q, Xu Z Open Life Sci. 2025; 20(1):20221051.

PMID: 40026360 PMC: 11868719. DOI: 10.1515/biol-2022-1051.


Investigating shared risk variants and genetic etiology between Alzheimer's disease and three stress-related psychiatric disorders: a large-scale genome-wide cross-trait analysis.

Dang W, Hao T, Li N, Zhang H, Li Z, Yu H Front Aging. 2025; 6:1488528.

PMID: 39975850 PMC: 11837265. DOI: 10.3389/fragi.2025.1488528.


Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function.

Alaei M, Koushki K, Taebi K, Yousefi Taba M, Keshavarz Hedayati S, Shahbaz S RSC Adv. 2025; 15(7):5426-5451.

PMID: 39967886 PMC: 11833603. DOI: 10.1039/d4ra07798a.


Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease.

Lee E, Chang Y Cells. 2025; 14(3).

PMID: 39936960 PMC: 11817173. DOI: 10.3390/cells14030168.


References
1.
Wang Y, Cella M, Mallinson K, Ulrich J, Young K, Robinette M . TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell. 2015; 160(6):1061-71. PMC: 4477963. DOI: 10.1016/j.cell.2015.01.049. View

2.
Dudvarski Stankovic N, Teodorczyk M, Ploen R, Zipp F, Schmidt M . Microglia-blood vessel interactions: a double-edged sword in brain pathologies. Acta Neuropathol. 2015; 131(3):347-63. DOI: 10.1007/s00401-015-1524-y. View

3.
Fu Y, Hsiao J, Paxinos G, Halliday G, Kim W . ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain. J Alzheimers Dis. 2016; 54(2):569-84. DOI: 10.3233/JAD-160456. View

4.
Shaked I, Porat Z, Gersner R, Kipnis J, Schwartz M . Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J Neuroimmunol. 2003; 146(1-2):84-93. DOI: 10.1016/j.jneuroim.2003.10.049. View

5.
Griciuc A, Serrano-Pozo A, Parrado A, Lesinski A, Asselin C, Mullin K . Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013; 78(4):631-43. PMC: 3706457. DOI: 10.1016/j.neuron.2013.04.014. View